4.5 Article

Advances in the study of HLA-restricted epitope vaccines

期刊

HUMAN VACCINES & IMMUNOTHERAPEUTICS
卷 9, 期 12, 页码 2566-2577

出版社

TAYLOR & FRANCIS INC
DOI: 10.4161/hv.26088

关键词

HLA restriction; epitope vaccine; adjuvant; MHC; bioinformatic

资金

  1. National Natural Science Foundation Project of China [81171604]
  2. China Postdoctoral Science Foundation [20110491573]

向作者/读者索取更多资源

Vaccination is a proven strategy for protection from disease. An ideal vaccine would include antigens that elicit a safe and effective protective immune response. HLA-restricted epitope vaccines, which include T-lymphocyte epitopes restricted by HLA alleles, represent a new and promising immunization approach. In recent years, research in HLA-restricted epitope vaccines for the treatment of tumors and for the prevention of viral, bacterial, and parasite-induced infectious diseases have achieved substantial progress. Approaches for the improvement of the immunogenicity of epitope vaccines include (1) improving the accuracy of the methods used for the prediction of epitopes, (2) making use of additional HLA-restricted CD8(+) T-cell epitopes, (3) the inclusion of specific CD4(+) T-cell epitopes, (4) adding B-cell epitopes to the vaccine construction, (5) finding more effective adjuvants and delivery systems, (6) using immunogenic carrier proteins, and (7) using multiple proteins as epitopes sources. In this manuscript, we review recent research into HLA-restricted epitope vaccines.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据